LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours. Scarzello, A. J., Jiang, Q., Back, T., Dang, H., Hodge, D., Hanson, C., Subleski J, Weiss JM, Stauffer JK, Chaisaingmongkol J, Rabibhadana S, Ruchirawat M, Ortaldo J, Wang XW, Norris PS, Ware CF, Wiltrout, R. H. (2016). Gut, 65(10), 1765-1775.

01 Oct 2016
0
0

LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours.
Scarzello, A. J., Jiang, Q., Back, T., Dang, H., Hodge, D., Hanson, C., Subleski J, Weiss JM, Stauffer JK, Chaisaingmongkol J, Rabibhadana S, Ruchirawat M, Ortaldo J, Wang XW, Norris PS, Ware CF, Wiltrout, R. H. (2016).
Gut, 65(10), 1765-1775.

Tags

Share this

Related Posts

Kitchen, P., Lee, K. Y., Clark, D., Lau, N., Lertsuwan, J., Sawasdichai, A., . . . Jayaraman, P. S. (2020). A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition. Cancer Res, 80(4), 757-770. doi:10.1158/0008-5472.CAN-19-0942
14 Feb 2020
0

Kitchen, P., Lee, K. Y., Clark, D., Lau, N., Lertsuwan, J., Sawasdichai, A., . . . Jayaraman, P. S. (2020). A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition. Cancer Res, 80(4), 757-770. doi:10.1158/0008-5472.CAN-19-0942

Kitchen, P., Lee, K. Y., Clark, D., Lau, N., Lertsuwan, J., Sawasdichai, A., . . . Jayaraman, P. S. (2020). A Runaway PRH/HHEX-Notch3-Positive Feedback Loop Drives Cholangiocarcinoma and Determines Response to CDK4/6 Inhibition. Cancer Res, 80(4), 757-770. doi:10.1158/0008-5472.CAN-19-0942
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
New
20 Sep 2023
0
New

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More